BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32372582)

  • 21. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
    Constantinou P; Dray-Spira R; Menvielle G
    BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The National Breast and Cervical Cancer Early Detection Program: toward a system of cancer screening in the United States.
    Smith RA; Brawley OW
    Cancer; 2014 Aug; 120 Suppl 16():2617-9. PubMed ID: 25099906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
    Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
    JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cancer screening programmes in Italy: unification element or factor for further division?].
    Zappa M; Federici A; Salmaso S
    Epidemiol Prev; 2011; 35(5-6 Suppl 2):100-2. PubMed ID: 22166878
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
    PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for cervical cancer in French Guiana: screening rates from 2006 to 2011.
    Douine M; Roué T; Lelarge C; Adenis A; Thomas N; Nacher M
    Bull Soc Pathol Exot; 2015 Dec; 108(5):355-9. PubMed ID: 26608273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Colorectal cancer screening programme in France, role of the National Institute of Cancer].
    Viguier J; Nathan Mle Q
    Med Sci (Paris); 2009 Mar; 25 Spec No 1():45-52. PubMed ID: 19361412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.
    Smith RA; Andrews KS; Brooks D; Fedewa SA; Manassaram-Baptiste D; Saslow D; Brawley OW; Wender RC
    CA Cancer J Clin; 2017 Mar; 67(2):100-121. PubMed ID: 28170086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System.
    Charkhchi P; Schabath MB; Carlos RC
    J Am Coll Radiol; 2019 Apr; 16(4 Pt B):607-620. PubMed ID: 30947895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Ruan Y; Heer E; Brenner DR
    Cancer; 2024 Jul; 130(13):2398. PubMed ID: 38642366
    [No Abstract]   [Full Text] [Related]  

  • 32. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACS releases updated guidelines on cancer screening.
    Lambert M
    Am Fam Physician; 2012 Sep; 86(6):571, 576-7. PubMed ID: 23062051
    [No Abstract]   [Full Text] [Related]  

  • 34. [EVE, a regional campaign for the screening of cervical cancer. Organization, 7-years results and perspectives].
    Fender M; Schott J; Baldauf JJ; Muller J; Schlund E; Dellenbach P;
    Presse Med; 2003 Oct; 32(33):1545-51. PubMed ID: 14576592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public awareness and cervical cancer screening.
    Davies P
    Cytopathology; 2012 Jun; 23(3):143-5. PubMed ID: 22587553
    [No Abstract]   [Full Text] [Related]  

  • 36. [In Italy, more and more women undertake tests for early diagnosis of cervical cancer within organized screening programmes].
    Carrozzi G; Sampaolo L; Bolognesi L; Bertozzi N; Ferrante G; Minardi V; Masocco M;
    Epidemiol Prev; 2016; 40(6):476. PubMed ID: 27919156
    [No Abstract]   [Full Text] [Related]  

  • 37. Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
    Baldauf JJ; Fender M; Bergeron C; Marrer E; Velten M; Pradat P; Arbyn M
    Eur J Cancer Prev; 2019 Jan; 28(1):33-39. PubMed ID: 29135538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.
    Beaber EF; Kim JJ; Schapira MM; Tosteson AN; Zauber AG; Geiger AM; Kamineni A; Weaver DL; Tiro JA;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv120. PubMed ID: 25957378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.
    Smith RA; Brooks D; Cokkinides V; Saslow D; Brawley OW
    CA Cancer J Clin; 2013; 63(2):88-105. PubMed ID: 23378235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for cancer: when to stop?: A practical guide and review of the evidence.
    Soung MC
    Med Clin North Am; 2015 Mar; 99(2):249-62. PubMed ID: 25700582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.